FBLG
Price:
$0.931
Market Cap:
$1.95M
FibroBiologics, Inc. operates as a clinical-stage biopharmaceutical firm, advancing therapies derived from fibroblasts toward commercialization within the United States. The company's pipeline includes CybroCell, currently being developed to address degenerative disc disease; CYMS101, targeting multiple sclerosis; and CYWC628 for wound repair. Further demonstrating its broad scope, early-stage investigations are underway for CYTER915, aimed at restoring or enhancing thymus and/or spleen function; CYPS317, for psoriasis; and TCB190, designed to combat specific cancers. FibroBiologics was founded in 2021 and is situated in Houston, Texas.
Industry
Biotechnology
IPO Date
2024-02-01
Stock Exchange
NASDAQ
Ticker
FBLG
According to FibroBiologics, Inc. Common Stock’s latest financial reports and current stock price. The company's current ROE is -767.07%. This represents a change of -43.28% compared to the average of -1352.26% of the last 4 quarters.
The mean historical ROE of FibroBiologics, Inc. Common Stock over the last ten years is -295.97%. The current -767.07% ROE has changed 159.17% with respect to the historical average. Over the past ten years (40 quarters), FBLG's ROE was at its highest in in the March 2024 quarter at 219.00%. The ROE was at its lowest in in the September 2025 quarter at -4622.40%.
Average
-295.97%
Median
-151.45%
Minimum
-1315.64%
Maximum
128.15%
Discovering the peaks and valleys of FibroBiologics, Inc. Common Stock ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual ROE = 128.15%
Minimum Annual Increase = -1126.62%
Minimum Annual ROE = -1315.64%
| Year | ROE | Change |
|---|---|---|
| 2025 | -302.89% | -25.78% |
| 2024 | -408.08% | -68.98% |
| 2023 | -1315.64% | -1126.62% |
| 2022 | 128.15% | 4.50% |
| 2021 | 122.64% | Infinity% |
The current ROE of FibroBiologics, Inc. Common Stock (FBLG) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-675.54%
5-year avg
-355.17%
10-year avg
-295.97%
FibroBiologics, Inc. Common Stock’s ROE is less than Daré Bioscience, Inc. (763.44%), greater than Athira Pharma, Inc. (-381.01%), less than Aditxt, Inc. (926.02%), greater than Ainos, Inc. (-160.55%), greater than Citius Pharmaceuticals, Inc. (-67.42%), less than Moleculin Biotech, Inc. (3.11%), greater than Leap Therapeutics, Inc. (-46.86%), less than Apollomics, Inc. (288.40%), greater than SeaStar Medical Holding Corporation (-146.29%), greater than Hoth Therapeutics, Inc. (-165.25%),
| Company | ROE | Market cap |
|---|---|---|
| 763.44% | $19.23M | |
| -381.01% | $26.62M | |
| 926.02% | $425.00 | |
| -160.55% | $8.65M | |
| -67.42% | $6.03M | |
| 3.11% | $14.09M | |
| -46.86% | $31.86M | |
| 288.40% | $15.78M | |
| -146.29% | $8.46M | |
| -165.25% | $14.92M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like FibroBiologics, Inc. Common Stock using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like FibroBiologics, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is FibroBiologics, Inc. Common Stock's ROE?
How is the ROE calculated for FibroBiologics, Inc. Common Stock (FBLG)?
What is the highest ROE for FibroBiologics, Inc. Common Stock (FBLG)?
What is the 3-year average ROE for FibroBiologics, Inc. Common Stock (FBLG)?
What is the 5-year average ROE for FibroBiologics, Inc. Common Stock (FBLG)?
How does the current ROE for FibroBiologics, Inc. Common Stock (FBLG) compare to its historical average?